Contract Manufacturing Industry News
-
Lonza Extends Tender Offer For All Outstanding Shares Of Arch Chemicals Common Stock To 30 September 2011
9/15/2011
Lonza Group Ltd, one of the world’s leading suppliers to the life science industries, announced recently that LG Acquisition Corp., an indirect wholly owned subsidiary of Lonza, has extended the expiration date for its previously announced tender offer for 100 percent of the outstanding shares of common stock of Arch Chemicals, Inc..
-
Single-Use BioFlex Tubing Assemblies Featured In New Brochure
8/25/2011
Meissner has just released a new brochure featuring its BioFlex tubing assemblies. The single-use tubing assemblies are designed for secure fluid transfer in critical biopharmaceutical processing applications.
-
FUJIFILM And Dr. Reddy’s To Establish An Exclusive Joint Venture For Developing, Manufacturing And Promoting Generic Drugs In Japan
8/4/2011
FUJIFILM Corporation (Head office: Tokyo, Japan) President and CEO, Shigetaka Komori (“Fujifilm” hereinafter) and Dr. Reddy's Laboratories Ltd. (Head office: Hyderabad, India) Vice-Chairman and CEO, G V Prasad ("Dr. Reddy’s" hereinafter) recently signed a Memorandum of Understanding (the “MoU” hereinafter) to enter into an exclusive partnership in the generic drugs business for the Japanese market and to establish a joint venture in Japan.
-
JHP Pharmaceuticals To Produce Clinical Batches Of Innovative Cardiac Drug
7/25/2011
JHP Pharmaceuticals, a leading provider of contract manufacturing services for sterile injectable products has entered into an agreement with an undisclosed biotech company to produce clinical trial batches of an innovative drug used in the treatment of heart failure.
-
Lonza Signs Manufacturing Deal With IMMUNE Pharmaceuticals For Bertilimumab (iCo-008)
7/19/2011
Lonza announced today an exclusive contract for the production of IMMUNE Pharmaceutical’s human immunoglobulin monoclonal antibody, Bertilimumab, under investigation for the potential treatment of several inflammatory disorders.
-
Dr. Reddy's Announces The Launch Of Amlodipine Besylate And Benazepril Hydrochloride Capsules
7/7/2011
Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Amlodipine Besylate and Benazepril Hydrochloride capsules (5 mg/40 mg and 10 mg/40 mg), a bioequivalent generic version of LOTREL®* capsules in the US market on July 5, 2011, following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy’s ANDA for Amlodipine Besylate and Benazepril Hydrochloride capsules.
-
JHP Pharmaceuticals Enters Agreement To Produce Life-Saving Drug
7/6/2011
JHP Pharmaceuticals, a leading provider of contract manufacturing services for sterile injectable products has entered into an agreement with an undisclosed pharmaceutical company. The agreement is for the product transfer and registration batch production of a life-saving drug.
-
Lonza’s New GS System Medium And Feed Platform Reaches 10g/L
6/30/2011
Lonza is launching a new cell culture medium and feed platform for the GS Gene Expression System that achieves product yields up to 10g/L.
-
inVentiv Health Completes Acquisition Of i3
6/16/2011
inVentiv Health, Inc., offering best-in-class clinical, consulting and commercial services to the healthcare industry, recently announced it has completed the acquisition of i3, a top-tier contract research organization (CRO) to the pharmaceutical, biotech and medical device industries.
-
Dr. Reddy’s Announces Three Generic Product Launches In The US Market
6/8/2011
Donepezil Hydrochloride tablets (5mg and 10mg strengths), a bioequivalent generic version of ARICEPT tablets. The Food & Drug Administration (FDA) approved Dr. Reddy’s ANDA for Donepezil HCl tablets on May 31, 2011. Both strengths of Dr. Reddy’s Donepezil Hydrochloride tablets are available in 30, 90 and 500 count bottles.
This website uses cookies to ensure you get the best experience on our website. Learn more